Page last updated: 2024-11-04

sulfadiazine and Cavernous Sinus Thrombophlebitis

sulfadiazine has been researched along with Cavernous Sinus Thrombophlebitis in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SEARS, TP1
WILSON, FL1

Other Studies

1 other study available for sulfadiazine and Cavernous Sinus Thrombophlebitis

ArticleYear
Recovery from cavernous sinus thrombosis and staphylococcic pneumonia by combined use of penicillin, sulfadiazine and antistaphylococcus serum; a case report.
    Rocky Mountain medical journal, 1945, Volume: 42

    Topics: Cavernous Sinus Thrombosis; Humans; Infections; Penicillins; Pneumonia; Sinus Thrombosis, Intracrani

1945